Nanotherapeutics to Present at 28th Annual Piper Jaffray Healthcare Conference

ALACHUA, Fla.–(BUSINESS WIRE)– Nanotherapeutics, Inc., a contract development and manufacturing
organization (CDMO), announced today that management will give a
corporate presentation at the 28^th Annual Piper Jaffray
Healthcare Conference. Additional information is as follows:

About Nanotherapeutics, Inc.

Nanotherapeutics is a contract development and manufacturing
organization (CDMO) that operates a U.S.-based 183,000 square foot,
state of the art, single-use, multi-purpose-multi- product, BSL-3
capable facility offering clients extensive capabilities, including a
pilot facility for performing optimization of upstream, downstream and
formulation functions, bulk cGMP manufacturing, and analytical
development for proteins, antibodies, viral vaccines and gene therapy
drug products. The Company provides expertise from preclinical through
FDA licensure in a variety of production platforms, including microbial
and mammalian cell culture. The Company also owns a second, Czech
Republic-based, 165,000 square foot, 6,000-liter capacity BSL-3 facility
for manufacturing vaccines using its proprietary Vero cell platform. For
more information, visit the Company website at www.nanotherapeutics.com.

Image may be NSFW.
Clik here to view.

View source version on businesswire.com: http://www.businesswire.com/news/home/20161122005866/en/